Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced that Vu Truong, Ph.D., Chief Executive Officer, will participate in Cantor Fitzgerald's Virtual Symposium: "Winning Ways to Treat Infections and COVID-19" being held on Tuesday, June 30, 2020. Read More »

The American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists appreciates the Food and Drug Administration's (FDA's) continuing efforts to review and advise the nation on the safe and effective use of hydroxychloroquine, chloroquine, and other medications to prevent and treat coronavirus. Read More »

Telehealth can be a new frontier for pharmacists, according to the incoming president of American Pharmacists Association, the association reported on its website. Read More »

An increasing number of groups are voicing their opposition to proposals by the Trump administration to force drug companies and medical device manufacturers to source materials in the United States, according to one trade organization. Read More »

Mylan achieves key milestone to provide U.S. multiple sclerosis patients with more affordable generic version of Biogen's Tecfidera® capsules Read More »

Kaiser Permanente to join as a governing member with the goal of helping to secure supplies of essential generic medications during COVID-19 and beyond Read More »

A bill introduced by U.S. Sen. Joni Ernst (R-IA) would give companies incentives if they brought their pharmaceutical, supply and medical device manufacturers back to the United States from China, the Ripon Advance reported. Read More »

While the development of COVID-19 vaccines is still in the early stages, a set of data from Moderna shows promising signs of efficacy, Managed Healthcare reported. Read More »

Pharmacy Times, the leading publication for pharmacists in the nation, in an independent survey conducted with U.S. News & World Report has again named Prevagen the #1 pharmacist recommended memory support brand. Read More »

Nature Made® is once again the leading choice of pharmacists in nine key vitamin and supplement segments, according to a broad survey and ranking of top recommended health products released by U.S. News & World Report, in collaboration with Pharmacy Times. Nature Made is ranked as the #1 Pharmacist Recommended brand for:1 Read More »

A pharmacy benefit manager believes that even though Big Pharma doesn't have a great reputation and is generally distrusted, these companies have stepped up their game in the wake of COVID-19 when it comes to development and research to help patients, Yahoo! Finance reports. Read More »

Sourcing activity for pharmaceutical contract manufacturing has gone up 234% since last year and 220% since last quarter, ThomasNet reported. Read More »

The Centers for Disease Control and Prevention has updated its guidance on providing non-COVID-19 clinical care during the pandemic. Read More »

A new report captures the progress and potential of immunotherapy to fight cancer a decade after the first treatment was approved by the U.S. Food and Drug Administration. Read More »

Gojji, a data-driven chronic care management company, has partnered with PerformRx, a URAC and NCQA-accredited full-service pharmacy benefit manager (PBM), to provide state- of-the-art chronic disease management products and best in class clinical services for their clients. Read More »

American Regent announces the introduction and availability of Estradiol Valerate Injection, USP – AO Rated and therapeutically equivalent to Delestrogen®1,2. Read More »

Under revised terms, AcelRx to acquire Tetraphase for $37.0 million in stock and cash plus CVRs Read More »

The new data was presented at the ASCO 2020 Virtual Scientific Program Read More »

Holograms could be a key tool in fighting fake pharmaceuticals, according to a story in European Pharmaceutical Manufacturer. Read More »

International reference pricing (IRP) for drugs is under consideration in the U.S. as health care experts are discussing an International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting to be held annually. Read More »